What is the current approximate market price of Fezonatant tablets?

Fezolinetant is a new oral drug mainly used to treat hot flashes in postmenopausal women. It effectively relieves hot flashes and other symptoms caused by decreased estrogen levels by selectively inhibiting specific receptors (such as NK3 receptors) in the neuroendocrine system. The drug was developed to provide postmenopausal women with a safer and more effective treatment option, especially since many patients have concerns or contraindications for traditional hormone replacement therapy.

As of now, fezonatant has not been launched in the Chinese market, so domestic patients cannot purchase this drug directly. In order to meet the needs of patients, some patients may choose to purchase the drug through overseas channels. Currently in the foreign market, the original drug specification of Fezonatant is usually 45mg*30 tablets, and each box sells for about more than 600 US dollars, which is about more than 4,000 yuan when converted into RMB. This price is subject to change due to exchange rate fluctuations, and specific conditions need to be adjusted based on real-time exchange rates.

In addition, in response to the demand of the international market, some generic drugs have emerged, such as the generic version of Fezonatan produced by Lucius, Laos. The ingredients of this kind of generic drug are basically the same as those of the original drug, but the price is relatively more affordable. The price of the same specifications is about more than 900 yuan. This provides a more economical option for patients who need the drug. Of course, patients should still pay attention to the source and quality of the drug when choosing to ensure the safety of the drug.

Since the efficacy and safety of fezonatant have performed well in clinical trials, the future prospects of this drug in the Chinese market are widely optimistic. Once approved, it will provide a new solution for the large number of women who experience hot flashes. At the same time, with the continuous adjustment of medical policies, the inclusion of drugs in medical insurance has also attracted much attention, which will directly affect patients' economic burden and drug accessibility.

Reference materials:https://www.veozah.com/